Monday, May 27, 2024

Alzheimer’s: Donanimab may be a breakthrough in treating and slowing the disease

Date:

Image copyright Getty Images

  • author, Fergus Walsh and Michael Roberts
  • stock, BBC News

A new drug called donanimab has been hailed as a breakthrough in the fight against Alzheimer’s disease, with results from a global trial confirming that it slows cognitive decline.

The antibody drug helps people with this type of dementia in the early stages of the disease by removing the protein that builds up in the brain.

Although there is no cure for everything, the charities say the findings, published in JAMA The Journal of the American Medical Association, mark a new era in the treatment of Alzheimer’s disease.

England’s Medicines Regulatory Authority has begun evaluating it for potential use in the National Health Service (NHS).

Nadia Barnett
Nadia Barnett
"Award-winning beer geek. Extreme coffeeaholic. Introvert. Avid travel specialist. Hipster-friendly communicator."

Share post:

Popular

More like this
Related

Cost-effective drilling: how to reduce operational expenses by smart equipment choices

Drilling costs affect the profitability and sustainability of oil...

Navigating the World of Cryptocurrencies: How to Choose the Best Crypto Wallet

In the digital age where cryptocurrencies are rapidly gaining...

Unlock the easiest way to get EU citizenship of Slovenia and Romania with Union Permits

Due to the nature of their immigration programs, Slovenia...

The Ultimate Guide to Men’s Facials in Dubai

In the bustling city of Dubai, where the sun...